UREA IS PRODUCED AS AN END product of protein catabolism in the liver and is ultimately excreted by the kidney. However, this unique small molecule of only 60 daltons is also used by the kidney to control water balance by a complex process that involves both secretion and reabsorption of urea throughout the entire renal tubule (11). Disturbance of these processes can cause a toxic buildup of urea in the blood termed uremia. Clearly, urea transporters (UT) are key players in this important process, and understanding UT activity, synthesis, turnover, and membrane trafficking has been a focus of researchers since the first gene was cloned in 1993 (17).
kDa form lacks this modification, which likely accounts for the mobility differences of the two forms on SDS gels (5) . More importantly, the 117-kDa form of UT-A1 is localized primarily to a unique membrane subdomain (termed a lipid raft) defined by its appearance exclusively in a low-density fraction of a sucrose flotation gradient after extraction with the detergent Brij 96V.
Using a similar approach, Su et al. (13) now show that the 67-kDa form of UT-A3 is also modified with poly-N-acetyllactosamine extensions when expressed in HEK293 cells while the 44 kDa form is not and that the 67-kDa form partitions exclusively into these low-density lipid rafts. Most interestingly, the 67-kDa form of UT-A3 is absolutely stable in HEK293 cells over 18 h, whereas the 44-kDa form (and the 97-kDa form of UT-A1) has a more typical half-life of ϳ10 h.
The correlation of UT modification with poly-N-acetyllactosamine extensions and its lipid raft association is intriguing. It is possible that the N-glycan modification with poly-Nacetyllactosamine extensions targets UT to lipid rafts or that association of UTs with lipid rafts results in modification of the UT N-glycans with poly-N-acetyllactosamine extensions. Both could be true. Chen et al. (5) already showed that the 97-kDa form of UT-A1 is present in lipid rafts within an hour of its synthesis in Madin-Darby canine kidney cells, whereas a mutant lacking consensus sites for N-linked glycosylation is not found in lipid rafts. These data could simply reflect reduced exit of mutant UT-A1 from the endoplasmic reticulum, which is often N-glycan-dependent for glycoproteins, or it could reflect a role for N-glycans in surface expression of UTs, since N-glycans on some transmembrane proteins act as apical targeting signals in polarized epithelial cells (10, 15) . Both roles for N-glycans could affect UT membrane trafficking and subsequent association with lipid rafts (16) . On the other hand, both the 97-kDa UT-A1 and the 44-kDa UT-A3, which both lack poly-N-acetyllactosamine extensions, are present in both the low-density lipid raft fractions and the high-density fractions of the sucrose gradient, consistent with modification of UT N-glycans once they are present in the lipid rafts. Because some apically expressed proteins are targeted by signals within their transmembrane domains through association with lipid rafts (defined by cold detergent insolubility and low density) (10, 15) , it becomes important to determine the mechanism for UT association with Brij 96V rafts.
Finally, it is not yet clear why the UT-A3 with poly-Nacetyllactosamine extensions has such a protracted stability or enhanced activity compared with UT-A1. The enhanced enzymatic activity of sucrase-isomaltase localized in lipid rafts (defined by its cold detergent solubility in Triton X-100) is dependent on terminal processing of both its N-linked and O-linked glycans and is attributed to cluster formation and cooperative interactions (16) . One factor that could be directly associated with the terminal processing of glycans (and clustering) is an association with galectins. Galectins are small lectin-like proteins that bind ␤-galactose-containing glycoconjugates and have been implicated to play a role in apical targeting of glycoproteins through cross-linking of either Nlinked or O-linked glycans, or even glycolipids (2, 6, 9) . Formation of multivalent lattices or microdomains through galectin cross-linking of cell surface receptors or solute transporters is a well-established phenomenon that reduces glycoprotein trafficking into endocytic compartments and thereby decreases the potential for degradation (2) . In short, UT modification with poly-N-acetyllactosamine extensions provides a prime target for binding of galectins and formation of seemingly stable complexes on the cell surface. Cell-specific regulation of glycosyltransferases that form these extensions could provide an additional level of regulation of UT expression and activity throughout the kidney tubule.
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